Navimox L Eye Drop is a combined pharmaceutical formulation containing Loteprednol Etabonate (0.5% w/v) and Moxifloxacin (0.5% w/v). This ophthalmic solution is indicated for the treatment of bacterial conjunctivitis and inflammation of the eye, including postoperative inflammation following cataract surgery. The corticosteroid, Loteprednol Etabonate, helps reduce inflammation, while Moxifloxacin, a fluoroquinolone antibiotic, targets a broad spectrum of bacteria. The coadministration of these two active ingredients aims to provide both effective bacterial eradication and rapid resolution of inflammation, ultimately promoting a faster recovery for the patient. Navimox L Eye Drop should be used under the supervision of a healthcare professional due to its potent antibacterial and anti-inflammatory properties.